fda schizophrenia news - Search News

FDA Approves 1st New Schizophrenia Drug in Decades

USA TODAY on MSN · 12h

This FDA-approved drug promises a new way to treat schizophrenia

Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than antipsychotic treatments

Time on MSN · 2d

FDA Approves the First New Schizophrenia Drug in Decades

No new treatments for schizophrenia have been approved in nearly three decades, but that changed on Sept. 26, when the U.S. Food and Drug Administration (FDA) approved Cobenfy for the psychiatric disorder.

FDA Approves Potentially Groundbreaking Schizophrenia Drug

On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel treatment for schizophrenia in decades.

The Washington Post on MSN3d

FDA approves a novel drug for schizophrenia, a potential ‘game changer’

“This drug takes the first new approach to schizophrenia treatment in decades,” Tiffany Farchione, director of FDA’s ...

FDA approves first new medication to treat schizophrenia in more than 30 years

People with schizophrenia will soon have a new treatment option after the FDA approved its first new treatment for the mental ...

FDA OKs First-in-Class Antipsychotic for Schizophrenia

The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.

MedPage Today2d

FDA Approves First Novel Drug for Schizophrenia in Decades

The FDA on Thursday approved xanomeline and trospium chloride (Cobenfy) for schizophrenia in adults, the first new class of ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results